Source: Bloom Health Partners.
  • Bloom Health Partners (BLMH) has been awarded an extension of its state-wide contract for testing in Texas for K-12 schools to the end of the 2022-2023 school year
  • Bloom’s program with schools in Texas includes both rapid and lab testing that covers the needs of schools as they plan for waves and variants associated with the pandemic
  • Bloom will conduct PCR testing in the company’s Dallas-based laboratory
  • Rapid tests will continue to be supplied to schools, with results data managed on Bloom’s cloud data platform
  • Bloom Health Partners Inc. (BLMH) is a global platform for healthcare security, diagnostic testing and occupational health-tech
  • Bloom Health Partners Inc. (BLMH) is down 56 per cent, trading at $0.11 per share at 3 PM ET

Bloom Health Partners (BLMH) has been awarded an extension of its state-wide contract for testing in Texas for K-12 schools.

Bloom’s program with schools in Texas, announced in January, includes both rapid and lab testing that covers the needs of schools as they plan for waves and variants associated with the pandemic.

Bloom will conduct PCR testing in the company’s Dallas-based laboratory. Rapid tests will continue to be supplied to schools, with results data managed on Bloom’s cloud data platform.

Management of test data and results can be supported by Bloom’s cloud software platform suite called Bloom Shield.

Designed for operational health for large organizations, Bloom Shield software covers several solutions in occupational health as part of the Company’s platform that includes clinical, labs and secure data management.

“We’re honoured to be an ongoing trusted health provider to schools in Texas,” said Andrew Morton, CEO of Bloom.

“Our team is focused on assisting schools in Texas to manage safety in the coming year through a strong clinical practice, supported by best-in-class labs and technology,” he added.

The company has also granted 125,000 stock options to an officer of the company, in accordance with the provisions of its stock option plan. The stock options are exercisable at a price of $0.40 per common share, have a term of five years and vest over a three-year period.

Bloom Health Partners Inc. (BLMH) is a global platform for healthcare security, diagnostic testing and occupational health tech.

Bloom Health Partners Inc. (BLMH) is down 56 per cent, trading at $0.11 per share at 3 PM ET.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.